ADCT Financial Statements

Balance sheet, income statement, cash flow, and dividends for Adc Therapeutics Sa (ADCT).


$192.41M Market Cap.

As of 03/27/2025 5:00 PM ET (MRY) • Disclaimer

ADCT Market Cap. (MRY)


ADCT Shares Outstanding (MRY)


ADCT Assets (MRY)


Total Assets

$321.98M

Total Liabilities

$524.62M

Total Investments

$0

ADCT Income (MRY)


Revenue

$70.84M

Net Income

-$157.85M

Operating Expense

$195.54M

ADCT Cash Flow (MRY)


CF Operations

-$123.83M

CF Investing

-$867.00K

CF Financing

$97.05M

ADCT Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2024

$0

0%

0%

0%

-

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

0%

0%

0%

-

2020

$0

0%

-

0%

-

ADCT Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$321,980,000 (-9.25%)

$354,782,000 (-32.95%)

$529,168,000 (-14.37%)

$617,972,000 (20.30%)

Assets Current

$307,390,000 (-8.59%)

$336,291,000 (-24.60%)

$446,015,000 (-15.07%)

$525,182,000 (16.59%)

Assets Non-Current

$14,590,000 (-21.10%)

$18,491,000 (-77.76%)

$83,153,000 (-10.39%)

$92,790,000 (46.72%)

Goodwill & Intangible Assets

$0 (0%)

$0 (0%)

$14,360,000 (5.73%)

$13,582,000 (33.43%)

Shareholders Equity

-$202,642,000 (-36.69%)

-$148,249,000 (-267.08%)

$88,727,000 (-46.58%)

$166,088,000 (-50.50%)

Property Plant & Equipment Net

$13,429,000 (-16.76%)

$16,133,000 (61.64%)

$9,981,000 (-11.12%)

$11,230,000 (136.02%)

Cash & Equivalents

$250,867,000 (-9.95%)

$278,598,000 (-14.66%)

$326,441,000 (-30.03%)

$466,544,000 (6.23%)

Accumulated Other Comprehensive Income

-$1,421,000 (-1427.96%)

-$93,000 (73.88%)

-$356,000 (-294.54%)

$183,000 (-25.31%)

Deferred Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Investments

$0 (0%)

$1,647,000 (-94.71%)

$31,152,000 (-24.45%)

$41,236,000 (-13.93%)

Investments Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Investments Non-Current

$0 (0%)

$1,647,000 (-94.71%)

$31,152,000 (-24.45%)

$41,236,000 (-13.93%)

Inventory

$18,387,000 (13.66%)

$16,177,000 (-12.86%)

$18,564,000 (66.91%)

$11,122,000 (0%)

Trade & Non-Trade Receivables

$20,316,000 (-19.32%)

$25,182,000 (-65.49%)

$72,971,000 (141.48%)

$30,218,000 (0%)

Trade & Non-Trade Payables

$18,029,000 (15.80%)

$15,569,000 (26.05%)

$12,351,000 (2.24%)

$12,080,000 (128.83%)

Accumulated Retained Earnings (Deficit)

-$1,493,318,000 (-11.82%)

-$1,335,472,000 (-23.58%)

-$1,080,685,000 (-16.85%)

-$924,885,000 (-33.10%)

Tax Assets

$0 (0%)

$0 (0%)

$26,757,000 (2.72%)

$26,049,000 (0%)

Tax Liabilities

$0 (0%)

$0 (0%)

$0 (0%)

$3,754,000 (2419.46%)

Total Debt

$121,627,000 (-2.21%)

$124,377,000 (5.97%)

$117,375,000 (-15.98%)

$139,698,000 (21.39%)

Debt Current

$0 (0%)

$1,467,000 (-89.19%)

$13,571,000 (78.47%)

$7,604,000 (64.13%)

Debt Non-Current

$121,627,000 (-1.04%)

$122,910,000 (18.41%)

$103,804,000 (-21.42%)

$132,094,000 (19.60%)

Total Liabilities

$524,622,000 (4.29%)

$503,031,000 (14.21%)

$440,441,000 (-2.53%)

$451,884,000 (153.60%)

Liabilities Current

$80,469,000 (18.91%)

$67,670,000 (-31.62%)

$98,957,000 (33.84%)

$73,935,000 (82.84%)

Liabilities Non-Current

$444,153,000 (2.02%)

$435,361,000 (27.49%)

$341,484,000 (-9.65%)

$377,949,000 (174.37%)

ADCT Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$70,837,000 (1.84%)

$69,558,000 (-66.86%)

$209,908,000 (518.89%)

$33,917,000 (0%)

Cost of Revenue

$5,949,000 (135.23%)

$2,529,000 (-44.77%)

$4,579,000 (228.72%)

$1,393,000 (0%)

Selling General & Administrative Expense

$85,909,000 (-18.87%)

$105,888,000 (-24.93%)

$141,058,000 (3.53%)

$136,242,000 (76.41%)

Research & Development Expense

$109,633,000 (-13.76%)

$127,127,000 (-32.34%)

$187,898,000 (18.92%)

$158,002,000 (11.24%)

Operating Expenses

$195,542,000 (-16.08%)

$233,015,000 (-29.17%)

$328,956,000 (11.80%)

$294,244,000 (34.20%)

Interest Expense

$50,211,000 (8.39%)

$46,325,000 (25.46%)

$36,924,000 (101.33%)

$18,340,000 (272.31%)

Income Tax Expense

$166,000 (-99.58%)

$39,106,000 (3333.36%)

$1,139,000 (105.30%)

-$21,479,000 (-6668.50%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

-$157,846,000 (34.25%)

-$240,053,000 (-54.08%)

-$155,800,000 (32.27%)

-$230,026,000 (6.60%)

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income

-$157,846,000 (34.25%)

-$240,053,000 (-54.08%)

-$155,800,000 (32.27%)

-$230,026,000 (6.60%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

-$157,846,000 (34.25%)

-$240,053,000 (-54.08%)

-$155,800,000 (32.27%)

-$230,026,000 (6.60%)

Weighted Average Shares

$97,159,966 (18.91%)

$81,712,166 (4.26%)

$78,372,680 (2.13%)

$76,739,770 (8.21%)

Weighted Average Shares Diluted

$97,159,966 (18.91%)

$81,712,166

-

-

Earning Before Interest & Taxes (EBIT)

-$107,469,000 (30.50%)

-$154,622,000 (-31.33%)

-$117,737,000 (49.50%)

-$233,165,000 (3.27%)

Gross Profit

$64,888,000 (-3.19%)

$67,029,000 (-67.36%)

$205,329,000 (531.32%)

$32,524,000 (0%)

Operating Income

-$130,654,000 (21.29%)

-$165,986,000 (-34.26%)

-$123,627,000 (52.76%)

-$261,720,000 (-19.36%)

ADCT Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

-$867,000 (73.04%)

-$3,216,000 (-28.23%)

-$2,508,000 (62.42%)

-$6,673,000 (-135.96%)

Net Cash Flow from Financing

$97,054,000 (31.38%)

$73,875,000 (12557.84%)

-$593,000 (-100.22%)

$267,394,000 (-45.98%)

Net Cash Flow from Operations

-$123,835,000 (-4.34%)

-$118,686,000 (-14.02%)

-$104,092,000 (54.24%)

-$227,495,000 (-35.38%)

Net Cash Flow / Change in Cash & Cash Equivalents

-$27,648,000 (42.43%)

-$48,027,000 (65.67%)

-$139,895,000 (-611.63%)

$27,343,000 (-91.55%)

Net Cash Flow - Business Acquisitions and Disposals

$0 (0%)

$0

-

-

Net Cash Flow - Investment Acquisitions and Disposals

$0 (0%)

$0

-

-

Capital Expenditure

-$867,000 (73.04%)

-$3,216,000 (-457.37%)

-$577,000 (83.18%)

-$3,430,000 (-328.21%)

Issuance (Repayment) of Debt Securities

$0 (0%)

$0 (0%)

-$6,502,000 (-113.37%)

$48,614,000 (-21.28%)

Issuance (Purchase) of Equity Shares

$61,292,000 (7829.11%)

$773,000 (-86.92%)

$5,909,000 (659.51%)

$778,000 (-99.82%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0

-

-

Effect of Exchange Rate Changes on Cash

-$83,000 (-145.11%)

$184,000 (188.46%)

-$208,000 (-3566.67%)

$6,000 (-97.45%)

Share Based Compensation

$6,568,000 (-51.33%)

$13,495,000 (-72.64%)

$49,322,000 (-18.45%)

$60,480,000 (60.92%)

Depreciation Amortization & Accretion

$3,276,000 (0.28%)

$3,267,000 (40.34%)

$2,328,000 (-11.48%)

$2,630,000 (33.37%)

ADCT Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

91.60% (-4.98%)

96.40% (-1.43%)

97.80% (1.98%)

95.90%

Profit Margin

-222.80% (35.44%)

-345.10% (-365.09%)

-74.20% (89.06%)

-678.20%

EBITDA Margin

-147.10% (32.40%)

-217.60% (-295.64%)

-55.00% (91.91%)

-679.70%

Return on Average Equity (ROAE)

90.10% (-83.74%)

554.00% (519.06%)

-132.20% (-28.60%)

-102.80% (6.80%)

Return on Average Assets (ROAA)

-46.70% (12.55%)

-53.40% (-85.42%)

-28.80% (31.75%)

-42.20% (44.18%)

Return on Sales (ROS)

-151.70% (31.76%)

-222.30% (-296.26%)

-56.10% (91.84%)

-687.50%

Return on Invested Capital (ROIC)

-83.80% (5.52%)

-88.70% (-37.52%)

-64.50% (51.54%)

-133.10% (61.97%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0% (0%)

Price to Earnings Ratio (P/E)

-1.23 (-117.35%)

-0.56 (70.73%)

-1.93 (71.34%)

-6.73 (20.70%)

Price to Sales Ratio (P/S)

2.73 (39.95%)

1.95 (35.98%)

1.43 (-96.86%)

45.7

Price to Book Ratio (P/B)

-0.95 (-3.15%)

-0.92 (-127.15%)

3.39 (-63.66%)

9.33 (37.94%)

Debt to Equity Ratio (D/E)

-2.59 (23.70%)

-3.39 (-168.35%)

4.96 (82.43%)

2.72 (412.43%)

Earnings Per Share (EPS)

-1.62 (44.90%)

-2.94 (-47.74%)

-1.99 (33.67%)

-3 (20.42%)

Sales Per Share (SPS)

0.73 (-14.34%)

0.85 (-68.22%)

2.68 (505.88%)

0.44 (0%)

Free Cash Flow Per Share (FCFPS)

-1.28 (14.01%)

-1.49 (-11.68%)

-1.34 (55.60%)

-3.01 (-26.38%)

Book Value Per Share (BVPS)

-2.09 (-14.99%)

-1.81 (-260.25%)

1.13 (-47.69%)

2.16 (-54.26%)

Tangible Assets Book Value Per Share (TABVPS)

3.31 (-23.68%)

4.34 (-33.90%)

6.57 (-16.59%)

7.88 (10.93%)

Enterprise Value Over EBIT (EV/EBIT)

0 (0%)

0 (0%)

0 (0%)

-5 (37.50%)

Enterprise Value Over EBITDA (EV/EBITDA)

-0.4 (-218.92%)

0.33 (204.72%)

-0.32 (93.77%)

-5.11 (35.38%)

Asset Turnover

0.21 (35.48%)

0.15 (-60.05%)

0.39 (525.81%)

0.06 (0%)

Current Ratio

3.82 (-23.14%)

4.97 (10.27%)

4.51 (-36.55%)

7.1 (-36.24%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

-$124,702,000 (-2.30%)

-$121,902,000 (-16.46%)

-$104,669,000 (54.67%)

-$230,925,000 (-36.77%)

Enterprise Value (EV)

$41,212,338 (181.88%)

-$50,331,634 (-236.96%)

$36,748,091 (-96.88%)

$1,177,158,354 (-37.68%)

Earnings Before Tax (EBT)

-$157,680,000 (21.53%)

-$200,947,000 (-29.93%)

-$154,661,000 (38.51%)

-$251,505,000 (-2.25%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$104,193,000 (31.16%)

-$151,355,000 (-31.15%)

-$115,409,000 (49.94%)

-$230,535,000 (3.57%)

Invested Capital

$112,271,000 (-15.52%)

$132,891,000 (-35.73%)

$206,785,000 (1.56%)

$203,609,000 (46.52%)

Working Capital

$226,921,000 (-15.52%)

$268,621,000 (-22.60%)

$347,058,000 (-23.09%)

$451,247,000 (10.06%)

Tangible Asset Value

$321,980,000 (-9.25%)

$354,782,000 (-31.08%)

$514,808,000 (-14.82%)

$604,390,000 (20.03%)

Market Capitalization

$192,412,338 (40.91%)

$136,546,366 (-54.63%)

$300,951,091 (-80.59%)

$1,550,143,354 (-31.71%)

Average Equity

-$175,176,750 (-304.25%)

-$43,333,500 (-136.76%)

$117,880,750 (-47.33%)

$223,820,500 (0.22%)

Average Assets

$337,701,000 (-24.82%)

$449,164,000 (-16.95%)

$540,819,000 (-0.86%)

$545,510,500 (67.50%)

Invested Capital Average

$128,268,250 (-26.39%)

$174,258,500 (-4.46%)

$182,396,750 (4.09%)

$175,229,000 (154.42%)

Shares

96,689,617 (17.55%)

82,256,847 (4.96%)

78,372,680 (2.13%)

76,739,770 (8.21%)